| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Atara Biotherapeutics, Inc.
13D/A
ATRA · 046513107
|
20.0% |
5/16/2025
Event 5/14/2025
|
||||
| Adiumentum Capital Fund I LP | 20.0% | |||||
| Adiumentum Capital Fund I GP LLC | 20.0% | |||||
| Gregory A. Ciongoli | 20.0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.